National Institute of Health and Clinical Excellence (NICE) - latest published guidance

NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health. The guidance is developed using the expertise of the NHS and the wider healthcare community including NHS staff, healthcare professionals, patients and carers, industry and the academic world. For more details on their guidance visit their website.

NICE has issued the following guidance to the NHS in England and Wales (March 2013):

• Conduct disorders in children and young people
• Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin
• Electrochemotherapy for metastases in the skin from tumours of non-skin origin
• Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma
• Hyperphosphataemia in chronic kidney disease
• Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction
• Insertion of endobronchial valves for treatment of persistent air leaks
• Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal)
• Percutaneous electrical nerve stimulation for refractory neuropathic pain
• Peripheral nerve-field stimulation for chronic low back pain    

Website: NICE published guidance March 2013